PROCLAIMING MAY 2026 AS "CYSTIC FIBROSIS AWARENESS MONTH" IN THE STATE OF DELAWARE.

153rd General Assembly (2025-2026) Introduced by Darius Brown and 19 co-sponsors

Delaware designates May 2026 as Cystic Fibrosis Awareness Month to promote public education, advocacy, and support for those affected.

Passed By Senate. Votes: 20 YES 1 ABSENT

Summary of SCR 186 (Session 153, Delaware)

Purpose and intent

SCR 186 proclaims May 2026 as “Cystic Fibrosis Awareness Month” in the State of Delaware.

The resolution is a ceremonial, observations-oriented measure intended to recognize and raise public awareness about cystic fibrosis (CF), its impact on individuals and families, and the importance of research, treatment, and support services.

Key provisions

Official designation: The Delaware Senate (via SCR 186) designates May 2026 as CF Awareness Month within the state.

Public acknowledgment: The resolution typically encourages state agencies, organizations, and the public to observe the month with activities that promote understanding of CF, advocacy, and education.

Ceremonial language: The bill expresses support for individuals living with CF and acknowledges contributions of patients, families, clinicians, researchers, advocacy groups, and healthcare providers.

Persons and entities affected

Individuals and families affected by cystic fibrosis may experience heightened visibility and awareness within Delaware.

CF organizations, healthcare providers, researchers, schools, community groups, and state agencies may undertake awareness activities, education campaigns, or events in alignment with the designation.

The resolution has no direct fiscal impact or regulatory changes; it primarily serves a symbolic and educational purpose.

Procedural and timeline aspects

Introduction and passage: SCR 186 was introduced and subsequently passed by the Delaware Senate on May 13, 2026 (votes: 20 Yes, 1 Absent).

Next steps: As a resolution, it would typically proceed to the Delaware House of Representatives for concurrence if applicable, and upon passage by both chambers, would become an official expression of the legislature. (Note: The provided history only mentions the Senate action; procedural steps in the House, if any, are not included.)

Effect: If enacted, the designation would apply to May 2026 and serve as a formal recognition rather than creating new laws or funding.

Context and significance

While relatively narrow in scope, proclamations like SCR 186 can bolster public awareness, encourage educational outreach, and support community engagement around CF.

The inclusion of a broad list of sponsors (numerous co-sponsors from both chambers indicates broad legislative support and coalition-building) suggests cross-party endorsement of raising CF awareness in Delaware.

If you would like, I can add background on cystic fibrosis (symptoms, prevalence, typical treatments) or outline potential events and awareness activities commonly associated with CF Awareness Month.